To view this email as a web page, click here

Today's Rundown

Featured Story

AstraZeneca scores win in Europe's COVID-19 vaccine lawsuit, saying it can easily beat court supply mandate

As Europe battled the COVID-19 pandemic and looked to AstraZeneca for a much-needed vaccine, officials there took an unusual step earlier this year of suing the company over supply shortcomings. But in a significant win for the drugmaker, a Brussels court mostly sided with the company in that case.

read more

Top Stories

U.K. doubles down on Innova's rapid COVID-19 test, after FDA urged users to throw it away

After the FDA urged anyone who had Innova Medical Group’s COVID-19 antigen test to stop using it and toss it in the trash, regulators across the pond have re-reviewed and now cleared the rapid diagnostic's use, while also extended its authorization.

read more

Healthcare executives call on Biden to take 'innovative, bold' steps to tackle health equity using AI, big data

More work to collaboratively analyze and act upon social determinants data will spur better outcomes and lower costs, according to provider and payer executives.

read more

Moderna plots 155 new hires in 2021 amid major mRNA vaccine manufacturing expansion

With a major COVID-19 vaccine manufacturing boost underway, Moderna is plotting new hires to fill its expanded production and lab space. The mRNA specialist has promised to hire at least 155 new employees in Massachusetts as part of a state tax incentive.

read more

COVID-19 tracker: Biden says U.S. headed toward summer of 'joy and freedom'; Innova's troubled test wins UK backing

President Joe Biden said the U.S. could see a summer of "joy and freedom" but warned that the rapidly-spreading Delta variant could pose a threat to unvaccinated Americans. Innova's rapid COVID-19 test, slammed by the FDA just a week ago, won support from U.K. regulators. And more headlines.

read more

Can semiconductor expertise be applied to biopharma manufacturing? Entegris bets $40M that it can

Entegris, a Massachusetts-based manufacturer of assemblies for semiconductors, is investing $40 million in its life sciences division. The company believes its expertise is a natural fit for the production of medicines.

read more